» Articles » PMID: 26010737

Environmental Mold and Mycotoxin Exposures Elicit Specific Cytokine and Chemokine Responses

Overview
Journal PLoS One
Date 2015 May 27
PMID 26010737
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Molds can cause respiratory symptoms and asthma. We sought to use isolated peripheral blood mononuclear cells (PBMCs) to understand changes in cytokine and chemokine levels in response to mold and mycotoxin exposures and to link these levels with respiratory symptoms in humans. We did this by utilizing an ex vivo assay approach to differentiate mold-exposed patients and unexposed controls. While circulating plasma chemokine and cytokine levels from these two groups might be similar, we hypothesized that by challenging their isolated white blood cells with mold or mold extracts, we would see a differential chemokine and cytokine release.

Methods And Findings: Peripheral blood mononuclear cells (PBMCs) were isolated from blood from 33 patients with a history of mold exposures and from 17 controls. Cultured PBMCs were incubated with the most prominent Stachybotrys chartarum mycotoxin, satratoxin G, or with aqueous mold extract, ionomycin, or media, each with or without PMA. Additional PBMCs were exposed to spores of Aspergillus niger, Cladosporium herbarum and Penicillium chrysogenum. After 18 hours, cytokines and chemokines released into the culture medium were measured by multiplex assay. Clinical histories, physical examinations and pulmonary function tests were also conducted. After ex vivo PBMC exposures to molds or mycotoxins, the chemokine and cytokine profiles from patients with a history of mold exposure were significantly different from those of unexposed controls. In contrast, biomarker profiles from cells exposed to media alone showed no difference between the patients and controls.

Conclusions: These findings demonstrate that chronic mold exposures induced changes in inflammatory and immune system responses to specific mold and mycotoxin challenges. These responses can differentiate mold-exposed patients from unexposed controls. This strategy may be a powerful approach to document immune system responsiveness to molds and other inflammation-inducing environmental agents.

Citing Articles

Indoor microbial exposure increases complement component C3a and -reactive protein concentrations in serum.

Karhuvaara O, Vilen L, Nuutila J, Putus T, Atosuo J Heliyon. 2024; 10(2):e24104.

PMID: 38293363 PMC: 10827445. DOI: 10.1016/j.heliyon.2024.e24104.


Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer's Disease and MCI: A Review.

Rao R, Subramaniam K, Gregory J, Bredesen A, Coward C, Okada S Int J Mol Sci. 2023; 24(2).

PMID: 36675177 PMC: 9865291. DOI: 10.3390/ijms24021659.


Differential effects of exposure to toxic or nontoxic mold spores on brain inflammation and Morris water maze performance.

Harding C, Liao D, Persaud R, DeStefano R, Page K, Stalbow L Behav Brain Res. 2023; 442:114294.

PMID: 36638914 PMC: 10460635. DOI: 10.1016/j.bbr.2023.114294.


Chronic Occupational Mold Exposure Drives Expansion of -Reactive Type 1 and Type 2 T-Helper Cell Responses.

Lauruschkat C, Etter S, Schnack E, Ebel F, Schauble S, Page L J Fungi (Basel). 2021; 7(9).

PMID: 34575736 PMC: 8471116. DOI: 10.3390/jof7090698.


Killing Two Birds with One Stone: Mold-induced Pulmonary Immune Responses and Arterial Remodeling.

Brain J, Sieber N, Rosenblum Lichtenstein J Am J Respir Cell Mol Biol. 2019; 62(5):537-538.

PMID: 31693387 PMC: 7193785. DOI: 10.1165/rcmb.2019-0386ED.


References
1.
Baxi S, Muilenberg M, Rogers C, Sheehan W, Gaffin J, Permaul P . Exposures to molds in school classrooms of children with asthma. Pediatr Allergy Immunol. 2013; 24(7):697-703. PMC: 3782748. DOI: 10.1111/pai.12127. View

2.
Pestka J, Yike I, Dearborn D, Ward M, Harkema J . Stachybotrys chartarum, trichothecene mycotoxins, and damp building-related illness: new insights into a public health enigma. Toxicol Sci. 2007; 104(1):4-26. DOI: 10.1093/toxsci/kfm284. View

3.
Dearborn D, Smith P, Dahms B, Allan T, Sorenson W, Montana E . Clinical profile of 30 infants with acute pulmonary hemorrhage in Cleveland. Pediatrics. 2002; 110(3):627-37. DOI: 10.1542/peds.110.3.627. View

4.
. Update: pulmonary hemorrhage/hemosiderosis among infants--Cleveland, Ohio, 1993-1996. MMWR Morb Mortal Wkly Rep. 1997; 46(2):33-5. View

5.
de Mello L, Bechara M, Sole D, Rodrigues V . TH1/TH2 balance in concomitant immediate and delayed-type hypersensitivity diseases. Immunol Lett. 2009; 124(2):88-94. DOI: 10.1016/j.imlet.2009.04.011. View